Gilead Sciences, 10% Owner: Kalaris Therapeutics KLRS Buy · Filed 23/06/28

Trade details

Type: Insider buy
Amount: $10,990,762.5
Shares · price: 2,930,870 sh · $3.75 a share
Held after: 16,635,286 sh
Stock: Kalaris Therapeutics KLRS
Person: Gilead Sciences10% Owner
Trade date: 23/06/27
Filed: 23/06/28
Days to filing: 1 days

Holdings up 21.4%

Insiders buying this week: 1 insiders
Holding change: +21.4%

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 23/05/28~23/07/27

Gilead Sciences's recent trades

Gilead Sciences10% Owner
BuyAssembly Biosciences
Buy
Assembly Biosciences
ASMB
2,295,920 sh
price in footnote
2,295,920 sh
Filed 25/10/03
Traded 25/08/08
Gilead Sciences10% Owner
BuyArcus Biosciences
Buy
Arcus Biosciences
RCUS
$15M
1,363,636 sh
$15M
Filed 25/02/20
Traded 25/02/18
Gilead Sciences10% Owner
BuyAssembly Biosciences
Buy
Assembly Biosciences
ASMB
$20.1M
940,499 sh
$20.1M
Filed 24/12/23
Traded 24/12/19
Gilead Sciences10% Owner
BuyXilio Therapeutics
Buy
Xilio Therapeutics
XLO
$1.8M
1,759,978 sh
$1.8M
Filed 24/12/19
Traded 24/12/18
Gilead Sciences10% Owner
BuyAssembly Biosciences
Buy
Assembly Biosciences
ASMB
179,500 sh
price in footnote
179,500 sh
Filed 24/06/20
Traded 24/06/17